Cargando…
Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
INTRODUCTION: Isavuconazole is an emerging therapeutic option for invasive infections caused by molds, especially aspergillosis and mucormycosis. Isavuconazole has predictable pharmacokinetics and good bioavailability. These attributes have led to some doubts regarding the need for therapeutic drug...
Autores principales: | Prayag, Parikshit Shirish, Soman, Rajeev N, Panchakshari, Shweta P, Ajapuje, Preeti S, Mahale, Namita P, Dhupad, Surabhi, Patwardhan, Sampada A, Naik, Sadanand S, Narawade, Sharwari, Athavale, Anand, Saseedharan, Sanjith, Melinkeri, Sameer, Prayag, Amrita P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291642/ https://www.ncbi.nlm.nih.gov/pubmed/37378040 http://dx.doi.org/10.5005/jp-journals-10071-24443 |
Ejemplares similares
-
Ceftazidime-avibactam with or without Aztreonam vs Polymyxin-based Combination Therapy for Carbapenem-resistant Enterobacteriaceae: A Retrospective Analysis
por: Prayag¹, Parikshit S, et al.
Publicado: (2023) -
Enzyme Patterns and Factors Associated with Mortality among Patients with Carbapenem Resistant Acinetobacter
Baumannii (CRAB) Bacteremia: Real World Evidence from a Tertiary Center in India
por: Prayag, Parikshit Shirish, et al.
Publicado: (2023) -
Author Reply: Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India
por: Prayag, Parikshit Shirish
Publicado: (2023) -
The Dominance of Candida auris: A Single-center Experience of 79 Episodes of Candidemia from Western India
por: Prayag, Parikshit S, et al.
Publicado: (2022) -
COVID-19 Associated Vertebral Osteomyelitis Caused by Aspergillus Species—A Case Series
por: Prayag, Parikshit S., et al.
Publicado: (2022)